1, on behalf of the International Myeloma Workshop Consensus Panel
Mayo Clinic
No affiliation available
Citations 1
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
Rajkumar, S. Vincent , Harousseau, Jean‐Luc, Durie, Brian G.M. , Dimopoulos, Meletios Α. , Kyle, Robert A. , Bladé, Joan , Richardson, Paul G. , Orlowski, Robert Z. , Avet‐Loiseau, Hervé , Palumbo, Antonio , Zonder, Jeffrey A. , Vesole, David H., Sezer, Orhan , Munshi, Nikhil C. , Miguel, Jesús F. San , 1, on behalf of the International Myeloma Workshop Consensus Panel, Cavo, Michèle , García‐Sánz, Ramón , Anderson, Kenneth C. , Richardson, Paul Gerard Guy , Orlowski, Robert Z. , Siegel, David S. , Jagannath, Sundar , Facon, Thierry T.F. , Lonial, Sagar , Ludwig, Heinz , 1, on behalf of the International Myeloma Workshop Consensus Panel, Rajkumar, S Vincent , Dimopoulos, Meletios A , San-Miguel, Jesus , Garcia-Sanz, Ramon
Blood | February 4, 2011 | Volume: 117 | Issue: 18 | Pages: 4691-4695
Abstract It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.